Skip to main content
CVS logo

CVS · CVS HEALTH Corp · Webcasts, Transcripts & Audio

Track CVS — free
Market Cap
$109.79B
Shares
1.28B
Volume · Nov 18 5.29M Avg daily vol (3M) 9.11M

CVS HEALTH Corp Webcasts

Earnings calls, investor updates, investor days and conferences for CVS HEALTH Corp (CVS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-11-09
CVS HEALTH Corp (CVS) November 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-11-04
CVS HEALTH Corp (CVS) Q3 2026 Earnings Call Transcript
Confident tone Separation into two public companies Health services 2027 headwinds 2026 financial performance and guidance
Revenue
$108.40B
▲ 5.4% YoY
Diluted EPS
$1.68
Gross margin
43.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-09
CVS HEALTH Corp (CVS) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
CVS HEALTH Corp (CVS) Q2 2026 Earnings Call Transcript
Confident tone 2026 guidance raise and 2027 outlook Aetna margin recovery and Medicare Advantage strength AI and technology investment
Revenue
$106.10B
▲ 7.3% YoY
Diluted EPS
$2.31
▲ 188.8% YoY
Gross margin
44.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2026-05-14
CVS HEALTH Corp (CVS) May 14, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
CVS HEALTH Corp (CVS) Q1 2026 Earnings Call Transcript
Confident tone Guidance raise and 2026 outlook Commercial business momentum and 2027 selling season Medicare Advantage and CMS rate notice
Revenue
$100.43B
▲ 6.2% YoY
Diluted EPS
$2.30
▲ 63.1% YoY
Gross margin
44.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-09
CVS HEALTH Corp (CVS) March 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-10
CVS HEALTH Corp (CVS) Q4 2025 Earnings Call Transcript
Confident tone Aetna margin recovery Medicare Advantage rate notice PBM and pharmacy services
Revenue
$105.69B*
▲ 8.2% YoY
Gross margin
44.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-29
CVS HEALTH Corp (CVS) Q3 2025 Earnings Call Transcript
Positive tone 2025 Guidance and 2026 Earnings Growth PBM / Caremark Client Recontracting Aetna/Medicare Advantage Stars Ratings and Recovery
Revenue
$102.87B
▲ 7.8% YoY
Diluted EPS
$-3.13
▼ 4571.4% YoY
Gross margin
44.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
CVS HEALTH Corp (CVS) Q2 2025 Earnings Call Transcript
Positive tone Health Care Delivery pressure at Oak Street Aetna recovery and margin improvement Caremark PBM performance and 2026 selling season
Revenue
$98.92B
▲ 8.4% YoY
Diluted EPS
$0.80
▼ 43.3% YoY
Gross margin
45.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
CVS HEALTH Corp (CVS) Q1 2025 Earnings Call Transcript
Positive tone Raised Full-Year EPS Guidance and Q1 Results Prior Authorization Improvements and Bundling Arkansas PBM Regulation and State Legislation Risk
Revenue
$94.59B
▲ 7% YoY
Diluted EPS
$1.41
▲ 60.2% YoY
Gross margin
46.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-12
CVS HEALTH Corp (CVS) Q4 2024 Earnings Call Transcript
Positive tone 2025 Guidance and EPS Outlook Aetna Turnaround PBM/Caremark Defense
Revenue
$97.71B*
▲ 4.2% YoY
Gross margin
43.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-06
CVS HEALTH Corp (CVS) Q3 2024 Earnings Call Transcript
Cautious tone Healthcare Benefits / Aetna Underperformance Oak Street and Signify Health Acquisitions Health Services / PBM Performance
Revenue
$95.43B
▲ 6.3% YoY
Diluted EPS
$0.07
▼ 96% YoY
Gross margin
44.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
CVS HEALTH Corp (CVS) Q2 2024 Earnings Call Transcript
Cautious tone Healthcare benefits segment pressure Pharmacy pricing model transformation Guidance revision
Revenue
$91.23B
▲ 2.6% YoY
Diluted EPS
$1.41
▼ 4.7% YoY
Gross margin
45.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
CVS HEALTH Corp (CVS) Q1 2024 Earnings Call Transcript
Cautious tone Medicare Advantage utilization pressure and guidance cut Health Care Delivery integration (Oak Street, Signify) Cordavis biosimilars and Humira formulary change
Revenue
$88.44B
▲ 3.7% YoY
Diluted EPS
$0.88
▼ 46.7% YoY
Gross margin
45.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-07
CVS HEALTH Corp (CVS) Q4 2023 Earnings Call Transcript
Balanced tone Medicare Advantage Utilization Pressure Medicare Advantage Membership Growth 2024 Guidance Revision
Revenue
$93.81B*
▲ 11.9% YoY
Gross margin
38.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
CVS HEALTH Corp (CVS) Q3 2023 Earnings Call Transcript
Revenue
$89.76B
▲ 10.6% YoY
Diluted EPS
$1.75
Gross margin
39.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
CVS HEALTH Corp (CVS) Q2 2023 Earnings Call Transcript
Revenue
$88.92B
▲ 10.3% YoY
Diluted EPS
$1.48
▼ 35.4% YoY
Gross margin
39.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
CVS HEALTH Corp (CVS) Q1 2023 Earnings Call Transcript
Revenue
$85.28B
▲ 11% YoY
Diluted EPS
$1.65
▼ 6.8% YoY
Gross margin
39.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-08
CVS HEALTH Corp (CVS) Q4 2022 Earnings Call Transcript
Revenue
$83.85B*
▲ 9.5% YoY
Gross margin
38.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
CVS HEALTH Corp (CVS) Q3 2022 Earnings Call Transcript
Revenue
$81.16B
▲ 10% YoY
Diluted EPS
$-2.59
▼ 315.8% YoY
Gross margin
37.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
CVS HEALTH Corp (CVS) Q2 2022 Earnings Call Transcript
Revenue
$80.64B
▲ 11% YoY
Diluted EPS
$2.29
▲ 9% YoY
Gross margin
38.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
CVS HEALTH Corp (CVS) Q1 2022 Earnings Call Transcript
Revenue
$76.83B
▲ 11.2% YoY
Diluted EPS
$1.77
▲ 5.4% YoY
Gross margin
40.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-09
CVS HEALTH Corp (CVS) Q4 2021 Earnings Call Transcript
Revenue
$76.60B*
▲ 10.1% YoY
Gross margin
39.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
CVS HEALTH Corp (CVS) Q3 2021 Earnings Call Transcript
Revenue
$73.79B
▲ 10% YoY
Diluted EPS
$1.20
▲ 29% YoY
Gross margin
39.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
CVS HEALTH Corp (CVS) Q2 2021 Earnings Call Transcript
Revenue
$72.62B
▲ 11.1% YoY
Diluted EPS
$2.10
▼ 7.1% YoY
Gross margin
40.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
CVS HEALTH Corp (CVS) Q1 2021 Earnings Call Transcript
Revenue
$69.10B
▲ 3.5% YoY
Diluted EPS
$1.68
▲ 9.8% YoY
Gross margin
40.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-16
CVS HEALTH Corp (CVS) Q4 2020 Earnings Call Transcript
Revenue
$69.55B*
▲ 4% YoY
Gross margin
39.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-06
CVS HEALTH Corp (CVS) Q3 2020 Earnings Call Transcript
Revenue
$67.06B
▲ 3.5% YoY
Diluted EPS
$0.93
▼ 20.5% YoY
Gross margin
38.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
CVS HEALTH Corp (CVS) Q2 2020 Earnings Call Transcript
Revenue
$65.34B
▲ 3% YoY
Diluted EPS
$2.26
▲ 51.7% YoY
Gross margin
38.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
CVS HEALTH Corp (CVS) Q1 2020 Earnings Call Transcript
Revenue
$66.75B
▲ 8.3% YoY
Diluted EPS
$1.53
▲ 40.4% YoY
Gross margin
39.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-12
CVS HEALTH Corp (CVS) Q4 2019 Earnings Call
Revenue
$66.89B
▲ 22.9% YoY
Diluted EPS
$1.33
Gross margin
37.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–32 of 32 webcasts
Key facts CIK 64803 CUSIP 126650100 13F (30d) 1823 filings 1708 filers Visit website Investor relations